v3.26.1
Condensed Consolidated Interim Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2026
Sep. 30, 2025
Current    
Cash and cash equivalents $ 127,422 $ 102,577
Incentive and tax receivables 932 809
Prepaid expenses and other current assets 412 429
Total Assets 128,766 103,815
Current Liabilities    
Accounts payable 2,520 4,249
Accrued liabilities - Note 3 3,734 3,892
Deferred grant income - Note 4 805 805
Total Liabilities 7,059 8,946
92,696,842 common stock (September 30, 2025 - 86,668,521) 93 87
Additional paid-in capital 515,081 477,230
Accumulated deficit (393,467) (382,448)
Total Stockholders’ Equity 121,707 94,869
Total Liabilities and Stockholders’ Equity $ 128,766 $ 103,815